Polynovo Limited (CALZF)
Polynovo Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Port Melbourne, VIC, AU. The stock last traded at $0.62, up 0.00% on the session, giving a market capitalisation of $428.3M. On trailing twelve-month figures it carries a trailing P/E of 66.08, a net margin of 7.2%. Its beta of 1.33 implies it has historically moved more than the broad market.
Polynovo Ltd. engages in the development of medical devices, utilizing the patented polymer technology NovoSorb. It focuses on biodegradable temporizing matrix (BTM) product. It operates through the United States of America, Australia and New Zealand, and Other Countries geographical segments. The company was founded on August 12, 1998 and is headquartered in Port Melbourne, Australia.
Polynovo Limited is most often compared with the following Healthcare names: